Acumen Pharmaceuticals, Inc. (ABOS) Operating cash flow 2020–2025
Acumen Pharmaceuticals, Inc. (ABOS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$115.5MFY2025 · since FY2020: -$7.5M → -$115.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$115.5M | -34.0% |
| FY2024 | -$86.2M | -100.2% |
| FY2023 | -$43.1M | -22.5% |
| FY2022 | -$35.2M | -95.7% |
| FY2021 | -$18.0M | -141.1% |
| FY2020 | -$7.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABOS financial trends
ABOS RevenueABOS Net incomeABOS Net marginABOS Gross profitABOS Gross marginABOS Operating incomeABOS Operating marginABOS Free cash flowABOS Capital expendituresABOS Return on equityABOS Stock buybacksABOS Dividends paidABOS Total assetsABOS Total liabilitiesABOS Shareholders’ equityABOS overview →